Phase I/II trial of tremelimumab in patients with metastatic melanoma.

Camacho LH, Antonia S, Sosman J, Kirkwood JM, Gajewski TF, Redman B, Pavlov D, Bulanhagui C, Bozon VA, Gomez-Navarro J, Ribas A
J Clin Oncol. 2009 27 (7): 1075-81

PMID: 19139427 · DOI:10.1200/JCO.2008.19.2435

MeSH Terms (15)

Adult Aged Aged, 80 and over Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Antineoplastic Agents Dose-Response Relationship, Drug Drug-Related Side Effects and Adverse Reactions Female Humans Infusions, Intravenous Male Melanoma Middle Aged Survival Analysis

Connections (1)

This publication is referenced by other Labnodes entities:

Links